Consortium Drafts Array Control Standards; Will They Make RNA More Accessible for PGx? | GenomeWeb

Microarray technology, long beset by widely differing data standards, may be one step closer to becoming a mainstream component of pharmacogenomics.

The External RNA Controls Consortium, an ad hoc group of 70 partners from industry, government, and academia seeking to develop a list of microarray and RT-PCR experimental controls, has published a draft of approximately 100 standard controls and a plan to test them, and is now seeking public comment on the draft before it becomes finalized at an ERCC meeting next month.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

In Nucleic Acids Research this week: ProTraits includes genetic, phenotypic data on bacteria, archaea; Candida albicans assembly 22; and more.

The Wall Street Journal reports that researchers are looking beyond Cas9 for CRISPR editing.

Familial DNA searches in criminal cases are winning over some critics, the Los Angeles Times reports.

In PNAS this week: miR-515 levels higher in women with preeclampsia, horizontal gene transfer in parasitic plants, and more.